China has emerged as a health tech superpower, leveraging its large population and efficient systems to advance digital healthcare through apps and telemedicine, while simultaneously becoming a major player in drug development with more clinical trials than the U.S. and half of global drug licensing deals. Western companies are increasingly licensing Chinese-developed medicines, though this rise has sparked both admiration and concerns about technology transfer and regulatory restrictions.